Picture of CervoMed logo

CRVO — CervoMed News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Diffusion Pharmaceuticals Reports Second Quarter Net Loss Per Share $2.06

Aug 11 (Reuters) - Diffusion Pharmaceuticals Inc  DFFN.O :
    * DIFFUSION PHARMACEUTICALS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * Q2 NET LOSS PER SHARE OF COMMON STOCK, BASIC AND DILUTED
$2.06

Source text for Eikon:  ID:nGNX7WDSy5 
Further company coverage:  DFFN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on CervoMed

See all news